CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2021; 30(04): e286-e292
DOI: 10.1055/s-0041-1730327
Original Article | Artículo Original

Gender Dysphoria in the Pediatric Population: Initial Experience of a Transdisciplinary Group

Disforia de género en la población pediátrica: experiencia inicial de un grupo transdisciplinario
Camila Moreno-Bencardino
1   Division of Urology, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, D.C, Colombia
,
2   Urology Department, Fundación Santa Fe de Bogotá, Universidad de los Andes, Bogotá, D.C, Colombia
,
1   Division of Urology, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, D.C, Colombia
2   Urology Department, Fundación Santa Fe de Bogotá, Universidad de los Andes, Bogotá, D.C, Colombia
,
3   Pediatric Endocrinology Division, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana. Bogotá, D.C, Colombia
,
Catalina Forero
3   Pediatric Endocrinology Division, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana. Bogotá, D.C, Colombia
,
4   Division of Urology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States
› Institutsangaben

Abstract

Introduction Although there is an increasing experience in the management of transgender individuals, this has not been thoroughly explored in children. The need to establish a comprehensive and transdisciplinary management is of critical importance. In order to solve this issue, we want to report the results of a cohort of individuals with gender dysphoria (GD) seen by our transdisciplinary group from a social and clinical and health access perspective.

Methods A 10-year retrospective case series of all patients that had been seen by our transdisciplinary team was reviewed. The main demographic characteristics were described, as well as impact variables in terms of diagnosis and treatment of these individuals. A social description of each individual was described. Frequency, distribution, and central tendency measures were evaluated for data presentation. IBM SPSS Statistics for Windows, version 24.0 (IBM Corp, Armonk, NY) software was used.

Results Four cases of GD were included. Three had male to female dysphoria and one female to male. The median reported age of GD awareness was 6 years old (between 4 and 8 years old), and the median time between GD awareness and the 1st medical evaluation was 7 years for all individuals. The median age at gender role expression was 12 years old (between 10 and 14 years old). All patients had already assumed their experienced gender role before the 1st evaluation by our group. The median age at the 1st evaluation by our group was 13 years old (between 10 and 16 years old); three of the patients were evaluated after initiation of puberty. In the present study, individuals with GD demonstrated having health care access barriers for their transition process. Referral times are high, and individuals with GD are cared after pubertal development, which is related to suboptimal outcomes. The spectrum of GD is broad, and management must be individualized according to expectations.

Conclusion Individuals with GD face multiple access barriers that limit their possibility of being seen by a transdisciplinary team. This reflects in longer waiting times that negatively impact medical management. Gender dysphoria is a wide spectrum, and individuals should be evaluated individually by a transdisciplinary team.

Resumen

Introducción En las ultimas décadas se ha ganado más experiencia en el manejo de individuos con disforia de genero (DG). Sin embargo, en la población pediátrica esto aun no se ha explorado completamente. La necesidad de ofrecer un manejo cuidadoso y transdisciplinario es de gran importancia. El objetivo de este estudio es presentar la experiencia de nuestro grupo transdisciplinario (GT) en el abordaje de pacientes con DG desde el punto de vista medico y social.

Materiales y métodos Se realizó un análisis descriptivo de los casos de DG en menores de 18 años tratados en los últimos 10 años por el GT de Desórdenes del Desarrollo e Identidad Sexual. Se usaron medidas de frecuencia y tendencia central para la presentación de datos mediante el programa SPSS, versión 24.0. Se realizó un análisis descriptivo de las variables: familia y dinámica social; evaluación psiquiátrica; expectativas; barreras de acceso; y abordaje del GT.

Resultados Se presentan cuatro casos de DG, tres hombre-mujer y uno mujer-hombre. La edad a la primera sensación de disforia (PSD) fue en promedio 5,7 años, y el tiempo medio entre la PSD y la primera evaluación médica (PEM) fue de 6,25 años. La edad promedio a la primera evaluación por el grupo (PEG) fue de 13,25 años; 3 individuos tenían pubertad avanzada y 1, incipiente. Dos individuos habían recibido atención médica antes de la PEG. Se identificó que, al momento de la valoración por el grupo, los individuos contaban con el apoyo de sus familiares, y el entorno escolar era cada vez más incluyente; en ninguno se identificó enfermedad psiquiátrica, y a todos se indicó acompañamiento por psicoterapia. La expectativa con el proceso fue heterogénea con respecto a procedimientos quirúrgicos, manejos hormonales y rol de género, dependiendo de las características físicas que generaban disforia (caracteres sexuales secundarios, genitales). Las barreras de acceso fueron el desconocimiento de los especialistas en primeras valoraciones y las administrativas. La decisión del grupo con respecto al manejo hormonal y quirúrgico, así como acompañamiento psicológico se individualizó para cada paciente.

Conclusiones Los individuos con DG presentan barreras de acceso a soporte médico para su proceso de transición. Los tiempos de atención son prolongados; por ende, son atendidos después de desarrollar la pubertad, lo cual se relaciona con desenlaces subóptimos. El espectro de la DG es amplio y se debe individualizar el manejo según las expectativas.



Publikationsverlauf

Eingereicht: 31. August 2020

Angenommen: 22. Dezember 2020

Artikel online veröffentlicht:
22. Dezember 2021

© 2021. Sociedad Colombiana de Urología. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Olson J, Schrager SM, Belzer M, Simons LK, Clark LF. Baseline Physiologic and Psychosocial Characteristics of Transgender Youth Seeking Care for Gender Dysphoria. J Adolesc Health 2015; 57 (04) 374-380
  • 2 Skordis N, Kyriakou A, Dror S, Mushailov A, Nicolaides NC. Gender dysphoria in children and adolescents: an overview. Hormones (Athens) 2020; 19 (03) 267-276
  • 3 Panagiotakopoulos L. Transgender medicine - puberty suppression. Rev Endocr Metab Disord 2018; 19 (03) 221-225
  • 4 Safer JD, Tangpricha V. Care of Transgender Persons. N Engl J Med 2019; 381 (25) 2451-2460 http://www.ncbi.nlm.nih.gov/pubmed/31851801
  • 5 Richards C, Bouman WP, Seal L, Barker MJ, Nieder TO, T'Sjoen G. Non-binary or genderqueer genders. Int Rev Psychiatry 2016; 28 (01) 95-102
  • 6 American Psychiatric Association. DSM-5. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.. 2013
  • 7 Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J. et al. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. https://doi.org/101080/155327392011700873 2012; 13 (04) 165-232
  • 8 Hembree WC, Cohen-Kettenis PT, Gooren L. et al. Endocrine treatment of gender-dysphoric/ gender-incongruent persons: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017; 102 (11) 3869-3903
  • 9 Joseph T, Ting J, Butler G. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort. J Pediatr Endocrinol Metab 2019; 32 (10) 1077-1081
  • 10 Edwards-Leeper L, Spack NP. Psychological evaluation and medical treatment of transgender youth in an interdisciplinary “Gender Management Service” (GeMS) in a major pediatric center. J Homosex 2012; 59 (03) 321-336
  • 11 Olson-Kennedy J, Chan Y-M, Rosenthal S. et al. Creating the Trans Youth Research Network: A Collaborative Research Endeavor. Transgend Health 2019; 4 (01) 304-312
  • 12 Fernandez N, Moreno O, Rojas A. et al. Manejo transdisciplinario de pacientes con desórdenes del desarrollo sexual en Colombia. Limitantes para un manejo oportuno e integral. Urol Colomb. 2017; 26 (03) 164-168
  • 13 Klaver M, de Mutsert R, Wiepjes C, Den Heijer M, Rotteveel J, Klink D. Hormonal treatment affects body composition and body shape in transgender adolescents. The Journal of Sexual Medicine 2018; 15: 251-260
  • 14 Emmanuel M, Bokor BR. Tanner Stages. The SAGE Encyclopedia of Lifespan Human Development. SAGE Publications, Inc.; 2018
  • 15 Martinerie L, Condat A, Bargiacchi A, Bremont-Weill C, de Vries MC, Hannema SE. MANAGEMENT OF ENDOCRINE DISEASE: Approach to the management of children and adolescents with Gender Dysphoria. Eur J Endocrinol 2018; 179 (05) R219-R237
  • 16 Kaltiala-Heino R, Bergman H, Työläjärvi M, Frisén L. Gender dysphoria in adolescence: current perspectives. Adolesc Health Med Ther 2018; 9: 31-41
  • 17 de Vries ALC, McGuire JK, Steensma TD, Wagenaar ECF, Doreleijers TAH, Cohen-Kettenis PT. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014; 134 (04) 696-704
  • 18 Cole CM, O'Boyle M, Emory LE, Meyer III WJ. Comorbidity of gender dysphoria and other major psychiatric diagnoses. Arch Sex Behav 1997; 26 (01) 13-26
  • 19 Zucker KJ, Lawrence AA, Kreukels BPC. Gender Dysphoria in Adults. Annu Rev Clin Psychol 2016; 12 (01) 217-247
  • 20 Mahfouda S, Moore JK, Siafarikas A. et al. Gender-affirming hormones and surgery in transgender children and adolescents. Lancet Diabetes Endocrinol 2019; 7 (06) 484-498
  • 21 Lefevor GT, Boyd-Rogers CC, Sprague BM, Janis RA. Health disparities between genderqueer, transgender, and cisgender individuals: An extension of minority stress theory. J Couns Psychol 2019; 66 (04) 385-395
  • 22 Baldwin A, Dodge B, Schick VR. et al. Transgender and genderqueer individuals' experiences with health care providers: What's working, what's not, and where do we go from here?. J Health Care Poor Underserved 2018; 29 (04) 1300-1318
  • 23 Steensma TD, Biemond R, de Boer F, Cohen-Kettenis PT. Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 2011; 16 (04) 499-516
  • 24 Bonifacio JH, Maser C, Stadelman K, Palmert M. Management of gender dysphoria in adolescents in primary care. CMAJ 2019; 191 (03) E69-E75
  • 25 Butler G, De Graaf N, Wren B, Carmichael P. Assessment and support of children and adolescents with gender dysphoria. Arch Dis Child 2018; 103 (07) 631-636
  • 26 Shumer DE, Spack NP. Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy. Curr Opin Endocrinol Diabetes Obes 2013; 20 (01) 69-73
  • 27 Spack NP, Edwards-Leeper L, Feldman HA. et al. Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics 2012; 129 (03) 418-425
  • 28 Miller A, Davidson S. Co-ordinating meaning within a gender identity development service: What can the theory of the co-ordinated management of meaning offer clinicians working with young people, and their families, exploring their gender identities. Clin Child Psychol Psychiatry 2019; 24 (02) 322-337